DEFINING TARGETS FOR ANTIFUNGAL STEWARDSHIP IN IMMUNOCOMPROMISED PATIENTS
Grant number: 1133479 | Funding period: 2017 - 2021
Patients with impaired immune systems are at risk of serious fungal infections. Antifungal medicines used to prevent and treat these infections can be toxic and costly. This project aims to review current antifungal use and improvement activities in place in health services, assess prescriber knowledge, and to evaluate current doses of echinocandin antifungals used in liver failure patients. This project will identify ways to improve antifungal use needed for effective and safe prescribing.